Nerea Lopetegui-Lia

9PUBLICATIONS
83CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 22, 2026
Assessing Practice Patterns of Antidepressant Medication and Tamoxifen Use Among Patients With Hormone Receptor-Positive Breast Cancer.

|Aug 21, 2024
Current and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.

Nerea Lopetegui-Lia, Revati Varma, Jame Abraham

|May 16, 2024
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

Francesco Schettini, Eva Blondeaux, Chiara Molinelli

|Jul 28, 2023
Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management.

Mariam Markouli, Fauzia Ullah, Serhan Unlu

|Jun 05, 2023
Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement.

Nerea Lopetegui-Lia, Danai Dima, David Scott Buchberger

|May 16, 2023
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Talal El Zarif, Amin H Nassar, Elio Adib

Pageof 2

Frequent Collaborators

2 joint publications

Danai Dima

1 joint publications

Jonathan S Harrison

1 joint publications

Talal El Zarif

1 joint publications

Amin H Nassar